Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System
NCT05354440 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2025-09-19
Summary
Long-Term Prospective Post Marketing Clinical Follow Up for Evaluation of the BioProtect Balloon Implant™ System
Conditions
Sponsors & Collaborators
-
BioProtect
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- Ireland
- Israel
- Netherlands
- Poland
- Portugal
Study Locations
More Related Trials
-
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy
NCT06599476 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
NCT05896371 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences
NCT01355185 ·Status: UNKNOWN
-
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci
NCT01639859 ·Status: COMPLETED ·Phase: NA
-
Rectal Spacers Use in Prostate Cancer Radiation Therapy
NCT06594887 ·Status: RECRUITING ·Phase: NA
-
The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)
NCT05208229 ·Status: TERMINATED
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
Identifying Prostate Brachytherapy Seeds Using MRI
NCT01878058 ·Status: COMPLETED ·Phase: NA
-
Sequential bpMRI for Suspicious Prostate Lesions
NCT07332832 ·Status: NOT_YET_RECRUITING
-
Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer
NCT06773598 ·Status: RECRUITING
-
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
NCT01858688 ·Status: COMPLETED ·Phase: NA
-
Investigation of PSMA PET/CT as an Imaging Biomarker in Solid Tumors
NCT03453528 ·Status: COMPLETED ·Phase: NA
-
PSMA-PET Registry for Recurrent Prostate Cancer
NCT03718260 ·Status: RECRUITING ·Phase: NA
-
An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel
NCT05735652 ·Status: COMPLETED
-
Prostate Cancer Screening Trial Using Imaging
NCT03702439 ·Status: COMPLETED
-
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
NCT02825875 ·Status: COMPLETED
-
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
NCT05761366 ·Status: RECRUITING ·Phase: PHASE2
-
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI
NCT01857037 ·Status: COMPLETED ·Phase: NA
-
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI
NCT00242112 ·Status: COMPLETED ·Phase: NA
-
Phase I Study MR-guided SBRT to PCa
NCT03935308 ·Status: WITHDRAWN ·Phase: NA
-
PRospective Prostate biOmarker Study
NCT03565289 ·Status: COMPLETED
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
NCT05799248 ·Status: RECRUITING ·Phase: PHASE3
-
The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate
NCT00841685 ·Status: COMPLETED ·Phase: NA
-
Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
NCT06260410 ·Status: RECRUITING